Literature DB >> 26551777

A prospective multicenter study of unrelated bone marrow transplants using a reduced-intensity conditioning regimen with low-dose ATG-F.

S Fuji1, S W Kim1, S Yano2, S Hagiwara3, H Nakamae4, M Hidaka5, T Ito6, K Ohashi7, K Hatanaka8, A Takami9, S Kurosawa1, T Yamashita1, T Yamaguchi10, T Fukuda1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26551777     DOI： 10.1038/bmt.2015.268

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  15 in total

1.  Low-intensity conditioning is sufficient to ensure engraftment in matched unrelated bone marrow transplantation.

Authors:  A Nagler; M Aker; R Or; E Naparstek; G Varadi; C Brautbar; S Slavin
Journal:  Exp Hematol       Date:  2001-03       Impact factor: 3.084

2.  Impact of in vivo T-cell depletion on outcome of AML patients in first CR given peripheral blood stem cells and reduced-intensity conditioning allo-SCT from a HLA-identical sibling donor: a report from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.

Authors:  F Baron; M Labopin; D Blaise; L Lopez-Corral; S Vigouroux; C Craddock; M Attal; P Jindra; H Goker; G Socié; P Chevallier; P Browne; A Sandstedt; R F Duarte; A Nagler; M Mohty
Journal:  Bone Marrow Transplant       Date:  2014-01-13       Impact factor: 5.483

3.  Dose-reduced conditioning and allogeneic hematopoietic stem cell transplantation from unrelated donors in 42 patients.

Authors:  M Bornhäuser; C Thiede; U Platzbecker; A Jenke; A Helwig; R Plettig; J Freiberg-Richter; C Röllig; G Geissler; K Lutterbeck; U Oelschlagel; G Ehninger
Journal:  Clin Cancer Res       Date:  2001-08       Impact factor: 12.531

4.  Impact of immune modulation with anti-T-cell antibodies on the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies.

Authors:  Robert J Soiffer; Jennifer Lerademacher; Vincent Ho; Fangyu Kan; Andrew Artz; Richard E Champlin; Steven Devine; Luis Isola; Hillard M Lazarus; David I Marks; David L Porter; Edmund K Waller; Mary M Horowitz; Mary Eapen
Journal:  Blood       Date:  2011-04-04       Impact factor: 22.113

5.  Chronic graft-versus-host disease: long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti-T-cell globulin ATG-Fresenius.

Authors:  Gérard Socié; Claudia Schmoor; Wolfgang A Bethge; Hellmut D Ottinger; Matthias Stelljes; Axel R Zander; Liisa Volin; Tapani Ruutu; Dominik A Heim; Rainer Schwerdtfeger; Karin Kolbe; Jiri Mayer; Johan A Maertens; Werner Linkesch; Ernst Holler; Vladimir Koza; Martin Bornhäuser; Hermann Einsele; Hans-Jochem Kolb; Hartmut Bertz; Matthias Egger; Olga Grishina; Jürgen Finke
Journal:  Blood       Date:  2011-04-05       Impact factor: 22.113

6.  Comparison of graft-versus-host-disease and survival after HLA-identical sibling bone marrow transplantation in ethnic populations.

Authors:  Hakumei Oh; Fausto R Loberiza; Mei-jie Zhang; Olle Ringdén; Hideki Akiyama; Takayoshi Asai; Shuichi Miyawaki; Shinichiro Okamoto; Mary M Horowitz; Joseph H Antin; Asad Bashey; Jennifer M Bird; Matthew H Carabasi; Joseph W Fay; Robert Peter Gale; Roger H Giller; John M Goldman; Gregory A Hale; Richard E Harris; Jean Henslee-Downey; Hans-Jochem Kolb; Mark R Litzow; Philip L McCarthy; Steven M Neudorf; Derek S Serna; Gerard Socié; Pierre Tiberghien; A John Barrett
Journal:  Blood       Date:  2004-10-14       Impact factor: 22.113

7.  Reduced-intensity conditioning regimen with low-dose ATG-F for unrelated bone marrow transplant is associated with lower non-relapse mortality than a regimen with low-dose TBI: a single-center retrospective analysis of 103 cases.

Authors:  Shigeo Fuji; Niina Ueno; Nobuhiro Hiramoto; Yoshitaka Asakura; Kimikazu Yakushijin; Yutaro Kamiyama; Saiko Kurosawa; Sung-Won Kim; Yuji Heike; Takuya Yamashita; Takahiro Fukuda
Journal:  Int J Hematol       Date:  2013-10-04       Impact factor: 2.490

8.  Risk factors for acute graft-versus-host disease after human leukocyte antigen-identical sibling transplants for adults with leukemia.

Authors:  Theresa Hahn; Philip L McCarthy; Mei-Jie Zhang; Dan Wang; Mukta Arora; Haydar Frangoul; Robert Peter Gale; Gregory A Hale; John Horan; Luis Isola; Richard T Maziarz; Jon J van Rood; Vikas Gupta; Joerg Halter; Vijay Reddy; Pierre Tiberghien; Mark Litzow; Claudio Anasetti; Stephen Pavletic; Olle Ringdén
Journal:  J Clin Oncol       Date:  2008-11-03       Impact factor: 44.544

9.  Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial.

Authors:  Jürgen Finke; Wolfgang A Bethge; Claudia Schmoor; Hellmut D Ottinger; Matthias Stelljes; Axel R Zander; Liisa Volin; Tapani Ruutu; Dominik A Heim; Rainer Schwerdtfeger; Karin Kolbe; Jiri Mayer; Johan A Maertens; Werner Linkesch; Ernst Holler; Vladimir Koza; Martin Bornhäuser; Hermann Einsele; Hans-Jochem Kolb; Hartmut Bertz; Matthias Egger; Olga Grishina; Gérard Socié
Journal:  Lancet Oncol       Date:  2009-08-18       Impact factor: 41.316

10.  Investigation of the freely available easy-to-use software 'EZR' for medical statistics.

Authors:  Y Kanda
Journal:  Bone Marrow Transplant       Date:  2012-12-03       Impact factor: 5.483
View more
  5 in total

1.  Impact of the presence of HLA 1-locus mismatch and the use of low-dose antithymocyte globulin in unrelated bone marrow transplantation.

Authors:  K Kawamura; J Kanda; S Fuji; M Murata; K Ikegame; K Yoshioka; T Fukuda; Y Ozawa; N Uchida; K Iwato; T Sakura; M Hidaka; H Hashimoto; T Ichinohe; Y Atsuta; Y Kanda
Journal:  Bone Marrow Transplant       Date:  2017-07-17       Impact factor: 5.483

2.  Impact of low-dose rabbit anti-thymocyte globulin in unrelated hematopoietic stem cell transplantation.

Authors:  Kodai Kuriyama; Shigeo Fuji; Yoshihiro Inamoto; Kinuko Tajima; Takashi Tanaka; Yoshitaka Inoue; Reiko Ito; Yoshiki Hayashi; Ayumu Ito; Saiko Kurosawa; Sung-Won Kim; Takuya Yamashita; Takahiro Fukuda
Journal:  Int J Hematol       Date:  2016-02-09       Impact factor: 2.490

Review 3.  Friend or foe? Mogamulizumab in allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia/lymphoma.

Authors:  Shigeo Fuji; Takero Shindo
Journal:  Stem Cell Investig       Date:  2016-10-31

Review 4.  Immune Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Justyna Ogonek; Mateja Kralj Juric; Sakhila Ghimire; Pavankumar Reddy Varanasi; Ernst Holler; Hildegard Greinix; Eva Weissinger
Journal:  Front Immunol       Date:  2016-11-17       Impact factor: 7.561

5.  Joint Modeling of Immune Reconstitution Post Haploidentical Stem Cell Transplantation in Pediatric Patients With Acute Leukemia Comparing CD34+-Selected to CD3/CD19-Depleted Grafts in a Retrospective Multicenter Study.

Authors:  Emilia Salzmann-Manrique; Melanie Bremm; Sabine Huenecke; Milena Stech; Andreas Orth; Matthias Eyrich; Ansgar Schulz; Ruth Esser; Thomas Klingebiel; Peter Bader; Eva Herrmann; Ulrike Koehl
Journal:  Front Immunol       Date:  2018-08-14       Impact factor: 7.561
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.